Clinical Trial Update: Open Label Controlled Trial of Eculizumab in Adult Patients With Plasma Therapy-sensitive Atypical Hemolytic Uremic Syndrome (aHUS) [Phase 2]

View source ↗

Summary

Phase 2 open-label trial evaluating eculizumab in adult patients with plasma therapy-sensitive atypical Hemolytic Uremic Syndrome; results were posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atypical Hemolytic Uremic Syndrome

Drugs mentioned

• Eculizumab (eculizumab)

Snippet

Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Atypical Hemolytic Uremic Syndrome | Phase 2 | Status: COMPLETED | Results posted: 2015-01-26